L-Moses |
Antagonist of KAT2B, KAT2A
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| KAT2B |
|
|
| KAT2A |
|
|
Antagonist
1-5 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
A selectivity thermal shift assay panel of 48 of the 61 expressed human Bromodomains was set up usin ...
Potency Cellular
In Vitro
KAT2B
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1002/anie.201610816
KAT2A
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1002/anie.201610816
In Vivo Validations
Mouse
Dose: 10 mg/kg
Route of delivery:
Oral
Plasma half life:
49 minutes
Systemic clearance:
ND
DOI Reference: 10.1002/anie.201610816
Negative Control Compounds
D-Moses
Orthogonal Probes def
GSK4027
Chemical Information
| Molecular Formula | C21H25N6+ |
| SMILEs | Cc1[nH]nc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)n[n+]12 |
| InChI | InChI=1S/C21H24N6/c1-14(19(26(3)4)16-10-6-5-7-11-16)22-20-17-12-8-9-13-18(17)21-24-23-15(2)27(21)25-20/h5-14,19H,1-4H3,(H,22,25)/p+1/t14-,19+/m0/s1 |
| Molecular weight | 361.21 Da |
| AlogP | 3.108320000000001 |
| HBond acceptors | 6 |
| HBond donors | 2 |
| Atoms | 52 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.